Valuation: DocMorris AG

Market Cap 503M 627M 537M 460M 863M 60B 875M 5.94B 2.32B 30.14B 2.35B 2.3B 99.69B P/E 2026 *
-6.14x
P/E 2027 * -13x
Enterprise Value 705M 879M 753M 645M 1.21B 84.11B 1.23B 8.32B 3.25B 42.25B 3.3B 3.23B 140B EV / Sales 2026 *
0.56x
EV / Sales 2027 * 0.52x
Free-Float
65.15%
Yield 2026 *
-
Yield 2027 * -
1 year 7.45
Extreme 7.454
7.45
3 years 7.45
Extreme 7.454
108.05
5 years 7.45
Extreme 7.454
425
10 years 7.45
Extreme 7.454
547
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2022
Director of Finance/CFO 56 01/10/2024
Chief Tech/Sci/R&D Officer - 01/11/2024
Director TitleAgeSince
Chairman 68 28/04/2022
Director/Board Member 53 23/05/2019
Director/Board Member 56 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
-27.18%-.--% - - 627M
+1.63%-2.13%-40.02%-6.39% 15.73B
0.00%+0.46%-40.83%-23.83% 6.72B
+0.49%+2.25%-18.13%-12.75% 6.36B
-0.83%-0.42%-2.29%-23.01% 4.32B
+0.65%-1.99%-18.04%-38.82% 3.24B
+2.09%-0.75%-45.36%-24.10% 3.05B
-2.91%-1.40%+2.26%-36.86% 2.99B
-1.97%-3.96%-15.32%-7.12% 2.55B
+1.20%-1.30%+44.28% - 2.4B
Average -2.68%-0.87%-14.83%-21.61% 5.26B
Weighted average by Cap. +0.12%-0.84%-24.32%-17.10%

Financials

2026 *2027 *
Net sales 1.25B 1.56B 1.33B 1.14B 2.14B 149B 2.17B 14.75B 5.75B 74.87B 5.85B 5.72B 248B 1.41B 1.76B 1.51B 1.29B 2.42B 168B 2.45B 16.64B 6.49B 84.45B 6.6B 6.45B 279B
Net income -86.01M -107M -91.93M -78.74M -148M -10.27B -150M -1.02B -396M -5.16B -403M -394M -17.06B -42.6M -53.15M -45.53M -38.99M -73.18M -5.08B -74.14M -503M -196M -2.55B -200M -195M -8.45B
Net Debt 202M 252M 216M 185M 347M 24.11B 352M 2.39B 931M 12.11B 946M 926M 40.07B 234M 292M 250M 214M 402M 27.94B 407M 2.76B 1.08B 14.03B 1.1B 1.07B 46.42B
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
1,337
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
9.955CHF
Average target price
10.92CHF
Spread / Average Target
+9.68%

Quarterly revenue - Rate of surprise